arrow
Back
I

Irena Chacón

Universite PSL

7H-index
35Paper Count
256Citation Count
Published Papers 8
Publication Date
SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors
err2023-10-31
err20
PREAI
errLopez-Cobo, Sheila; Fuentealba, Jaime R.; Gueguen, Paul; Bonte, Pierre-Emmanuel; Tsalkitzi, Kyriaki; Chacon, Irena; Glauzy, Salome; Bohineust, Armelle; Biquand, Ariane; Silva, Lisseth; Gouveia, Zelia; Goudot, Christel; Perez, Franck; Saitakis, Michael; Amigorena, Sebastian
errShare
errSave
Phase III study of palbociclib (PD-0332991) in combination with endocrine therapy (exemestane or fulvestrant) versus chemotherapy (capecitabine) in hormonal receptor (HR) positive/HER2 negative metastatic breast cancer (MBC) patients with resistance to aromatase inhibitors. The PEARL study (GEICAM/2013-02)
err2017-02-15
err2
PREAI
errMartin, M.; Kahan, Z.; Carrasco, E.; Bartlett, C. H.; Casas, M.; Gil-Gil, M.; Munoz, M.; Ciruelos, E. M.; Ruiz-Borrego, M.; Margeli, M.; Anton, A.; Bermejo, B.; Morales, S.; Gal-Yam, E.; Koehler, M.; Garcia-Saenz, J. A.; de la Haba, J.; Chacon, I.; Zielinski, C.
errShare
errSave
CASCADE study: pronounced decline in treatment efficacy through the metastatic life of breast cancer patients
err2016-10-01
err1
errOAAI
errDe Paz Arias, L.; Garcia Teijido, P.; Servitja, S.; Santaballa, A.; Garcia, J.; Plata Fernandez, Y.; Garau, I.; Florian, J.; Chacon, I.; de la Haba, J.; Zamora, P.; Orcajo Rincon, L.; Rodriguez-Villanueva, J.; Segui, M. A.; Martinez, E.
errShare
errSave
Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer
err2016-10-01
err0
errOAAI
errChica-Parrado, M. R.; Santonja, A.; Lluch-Hernandez, A.; Albanell, J.; Sanchez-Munoz, A.; Chacon, I.; Calvo, L.; Sanchez-Rovira, P.; De la Haba, J.; Vicioso, L.; Martin, M.; Plazaola, A.; Prat, A.; Ribelles, N.; Sanchez-Arago, M.; Jerez, J. M.; Escudero, M. J.; Caballero, R.; Carrasco, E.; Alba Conejo, E.
errShare
errSave
Single arm, multicentre, non-randomized open-label trial to evaluate the safety of eribulin in third line chemotherapy in patients with HER2-negative metastatic or locally advanced breast cancer previously treated with anthracyclines and taxanes: Onsite study (ONCOSUR 2012-02)
err2016-10-01
err0
errOAAI
errManso Sanchez, L. M.; Moreno Anton, F.; Izarzugaza Peron, Y.; Delgado Mingorance, J. I.; Borrega, P.; Echarri Gonzalez, M. J.; Martinez, N.; Lopez Gonzalez, A.; Olier, C.; Ballesteros Garcia, A.; Chacon, I.; Ciruelos, E.; Garcia-Saenz, J. A.; Paz-Ares, L.
errShare
errSave
CASCADE study: Treatment and clinical outcomes of metastatic breast cancer by tumor immunophenotypes
err2016-02-15
err1
PREAI
errZamora, P.; Servitja, S.; Santaballa, A.; Garcia, J.; de Paz, L.; Plata, Y.; Garau, I.; Florian, J.; Chacon, I.; de la Haba, J.; Garcia, P.; Artime, E.; Rodriguez-Villanueva, J.; Velasco, A.; Martinez, E.; Segui, M. A.
errShare
errSave
CASCADE study: Longer overall survival in the novo versus recidivant patients with locally advanced/metastatic breast cancer
err2016-02-15
err0
PREAI
errServitja, S.; Zamora, P.; Santaballa, A.; Garcia, J.; de Paz, L.; Plata, Y.; Garau, I.; Florian, J.; Chacon, I.; de la Haba, J.; Garcia, P.; San Jose, B.; Rodriguez-Villanueva, J.; Orcajo, L.; Martinez, E.; Segui, M. A.
errShare
errSave
p27KIP1 is abnormally expressed in diffuse large B-cell lymphomas and is associated with an adverse clinical outcome
err1999-06-11
err40
errOAAI
errSáez, AI; Sánchez, E; Sánchez-Beato, M; Cruz, MA; Chacón, I; Muñoz, E; Camacho, FI; Martínez-Montero, JC; Mollejo, M; García, JF; Piris, MA
errShare
errSave